Seaport Therapeutics (SPTX) CEO Zohar gifted 100,000 shares
Alpha Vantage · Quantisnow · · AI-summarised by FinFlash
Daphne Zohar, CEO of Seaport Therapeutics (SPTX), reported gifting 100,000 shares of common stock to a donor-advised fund on November 10, 2026. This transaction, marked as a bona fide gift (Code G) on an SEC Form 4, reduced her direct holdings to 1,094,001 shares. The article details the transaction, explains the SEC Form 4 codes, and provides context on other recent insider activity at SPTX.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.